Michael L. Pennell
Michael L. Pennell is associate professor in the Division of Biostatistics in the College of Public Health at The Ohio State University. His research interests are in nonparametric Bayes, first hitting time models for survival analysis, design and analysis of Group Randomized Trials, joint modeling outcomes of different scales, statistical methods in toxicological risk assessment, and statistical applications in biomedical research, including cancer control, pathology, and veterinary medicine. Dr. Pennell has served as an ad hoc member of EPA’s Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Scientific Advisory Panel, the agency’s Science Advisory Board on trichloroethylene and Libby Amphibole Asbestos, and the Chemical Safety Advisory Subcommittee for 1-bromopropane. He received his MS and PhD in biostatistics from the University of North Carolina at Chapel Hill.
Karen A. Robinson
Karen A. Robinson is a professor at the Johns Hopkins University School of Medicine. She is also director of the Johns Hopkins University Evidence-based Practice Center and is a member of the core faculty in the Center for Clinical Trials and Evidence Synthesis at the university’s Bloomberg School of Public Health. Dr. Robinson’s research focuses on evidence-based health care and evidence-based research. She conducts systematic reviews that are used to develop clinical practice guidelines and to inform other health decisions. She served on the National Academies Committee on Endocrine-Related Low-Dose Toxicity, the Committee to Review Advances Made to the IRIS Process, and the Committee on gulf War and Health: Treatment of Chronic Multisymptom Illness. Dr. Robinson received an MSc in health sciences from the University of Waterloo, Ontario, and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health.
J. Christopher States
J. Christopher States is professor and vice chair for research in the Department of Pharmacology and Toxicology at the University of Louisville. His research interests are in arsenic carcinogenesis, arsenic-induced cardiovascular disease, disruption of mitosis and chemotherapy, and molecular biology and genetics of human DNA repair. Dr. States is an active member of the Society of Toxicology; he has served as president of the Metals Specialty Section and was the recipient of the section’s Career Achievement Award in 2017. He received his PhD in molecular biology and pathology from Albany Medical College, Union University.
Daniele Wikoff is the Health Sciences Practice Director at ToxStrategies, Inc. She specializes in evaluating human health hazards and risks associated with exposures to a wide variety of consumer products, food ingredients and additives, pharmaceuticals, and industrial chemicals. Her current focus is on systematic reviews in support of risk assessment applications, including development of health-based toxicity values. Dr. Wikoff has led the firm’s initiatives to integrate evidence-based methods, and has been responsible for designing and implementing projects involving systematic review and systematic maps using a variety of frameworks, including those of the Institute of Medicine and the NTP’s Office of Health Assessment and Translation. Most recently, she has been involved in exploring the utility of quantitative integration techniques (e.g., meta-analysis, Bayesian modeling) and tools to characterize confidence and/or uncertainty in hazard analyses, points of departure, estimate of relative potency, and dose-response relationships. Dr. Wikoff is vice chair of the Science Advisory Council for the Evidence-Based Toxicology Collaboration (EBTC), serves as EBTC’s Education Workgroup co-chair, and is on the editorial boards of Toxicological Sciences and Toxicology Reports. She received her PhD in toxicology from the University of North Carolina at Chapel Hill.
Carol S. Wood
Carol S. Wood is a distinguished staff scientist in the Environmental Science Division of Oak Ridge National Laboratory. She has over 20 years of experience as a toxicologist, with extensive work performing risk assessments of inhalation/pulmonary and oral toxicity from exposure to a variety of chemicals. Her past work has included developing acute exposure guideline levels and provisional advisory levels, in which health-based exposure levels are developed for priority toxic chemicals. These projects often used toxicokinetic data and physiologically based pharmacokinetic models for extrapolating animal toxicology data to humans. Dr. Wood is a past-president of the American Board of Toxicology. She is certified in general toxicology by the American Board of Toxicology. She served on the National Academies Committee on the Review of Clinical Guidance for the Care of Health Conditions Identified by the Camp Lejeune Legislation, the Committee on Spacecraft Exposure Guidelines, and on the Committee on Gulf War and Health, Volume 11 (Generational Health Effects of Serving in the Gulf War); she currently serves on the Committee on Toxicology. Dr. Wood received her MS in toxicology from Mississippi State University and her PhD in toxicology from Oregon State University.
Robert O. Wright
Robert O. Wright is a pediatrician, medical toxicologist, and environmental epidemiologist at the Icahn School of Medicine at Mount Sinai. He is the Ethel H. Wise Chair of the Department of Environmental Medicine and Public Health and director of the Institute for Exposomic Research. His research interests are in studies of chemical mixtures, social stressors as a modifier of chemical toxicity, and the role of genetics/epigenetics in modifying or mediating chemical toxicity. Dr. Wright was recently appointed to the National Advisory Environmental Health Science Council, a Congressionally mandated body that advises the secretary of Health and Human Services, the director of the National Instiutes of Health, and the director of the National Institute of Environmental Health Sciences (NIEHS) on matters relating to the direction of research, research support, training, and career development supported by NIEHS. He was a member of the National Academies Committee on Inorganic Arsenic, and currently serves on the Committee on Gulf War and Health (Volume 11): Generational Health Effects of Serving in the Gulf War. He received his MD from the University of Michigan and his MPH from the Harvard School of Public Health.